Cutler Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-15,600
| Closed | -$9K | – | 2172 |
|
|
2023
Q4 | $9K | Buy |
15,600
+1,100
| +8% | +$160K | ﹤0.01% | 2424 |
|
|
2023
Q3 | $86K | Sell |
14,500
-400
| -3% | -$58.7K | 0.01% | 1203 |
|
|
2023
Q2 | $127K | Buy |
14,900
+14,000
| +1,556% | +$2.05M | 0.02% | 806 |
|
|
2023
Q1 | $5K | Sell |
900
-31,900
| -97% | -$4.88M | ﹤0.01% | 2678 |
|
|
2022
Q4 | $54K | Sell |
32,800
-4,100
| -11% | -$629K | ﹤0.01% | 1515 |
|
|
2022
Q3 | $295K | Sell |
36,900
-46,600
| -56% | -$6.69M | 0.02% | 775 |
|
|
2022
Q2 | $146K | Sell |
83,500
-97,300
| -54% | -$14.9M | 0.01% | 1188 |
|
|
2022
Q1 | $168K | Buy |
180,800
+114,100
| +171% | +$16.6M | 0.01% | 1318 |
|
|
2021
Q4 | $45K | Buy |
66,700
+10,000
| +18% | +$1.18M | ﹤0.01% | 2473 |
|
|
2021
Q3 | $251K | Sell |
56,700
-125,100
| -69% | -$14.3M | 0.01% | 1206 |
|
|
2021
Q2 | $53K | Buy |
181,800
+149,200
| +458% | +$16.8M | ﹤0.01% | 2431 |
|
|
2021
Q1 | $26K | Sell |
32,600
-37,400
| -53% | -$4M | ﹤0.01% | 2961 |
|
|
2020
Q4 | $61K | Buy |
70,000
+65,200
| +1,358% | +$6.27M | ﹤0.01% | 1847 |
|
|
2020
Q3 | $24K | Sell |
4,800
-2,400
| -33% | -$226K | ﹤0.01% | 2302 |
|
|
2020
Q2 | $31K | Sell |
7,200
-16,500
| -70% | -$1.45M | ﹤0.01% | 2065 |
|
|
2020
Q1 | $221K | Buy |
23,700
+8,600
| +57% | +$733K | 0.01% | 891 |
|
|
2019
Q4 | $75K | Sell |
15,100
-4,500
| -23% | -$374K | ﹤0.01% | 1359 |
|
|
2019
Q3 | $194K | Sell |
19,600
-5,500
| -22% | -$377K | 0.02% | 715 |
|
|
2019
Q2 | $252K | Buy |
25,100
+8,200
| +49% | +$645K | 0.02% | 591 |
|
|
2019
Q1 | $60K | Buy |
+16,900
| New | +$1.38M | 0.01% | 1307 |
|
|
2018
Q4 | – | Sell |
-5,100
| Closed | -$1K | – | 3837 |
|
|
2018
Q3 | $1K | Sell |
5,100
-14,600
| -74% | -$1.38M | ﹤0.01% | 3674 |
|
|
2018
Q2 | $49K | Sell |
19,700
-1,500
| -7% | -$146K | ﹤0.01% | 1617 |
|
|
2018
Q1 | $71K | Sell |
21,200
-12,500
| -37% | -$1.37M | 0.01% | 1422 |
|
|
2017
Q4 | $11K | Sell |
33,700
-4,500
| -12% | -$424K | ﹤0.01% | 3021 |
|
|
2017
Q3 | $25K | Sell |
38,200
-15,000
| -28% | -$1.14M | ﹤0.01% | 2899 |
|
|
2017
Q2 | $44K | Sell |
53,200
-64,700
| -55% | -$4.35M | ﹤0.01% | 2611 |
|
|
2017
Q1 | $132K | Sell |
117,900
-67,000
| -36% | -$4.21M | 0.01% | 1494 |
|
|
2016
Q4 | $285K | Buy |
184,900
+32,600
| +21% | +$1.99M | 0.01% | 1049 |
|
|
2016
Q3 | $260K | Sell |
152,300
-145,600
| -49% | -$9.43M | 0.01% | 1014 |
|
|
2016
Q2 | $358K | Buy |
297,900
+20,600
| +7% | +$1.26M | 0.02% | 763 |
|
|
2016
Q1 | $504K | Buy |
277,300
+13,400
| +5% | +$747K | 0.03% | 522 |
|
|
2015
Q4 | $346K | Buy |
+263,900
| New | +$15.2M | 0.02% | 812 |
|
Other funds holding ABBV
Cutler Group's ABBV Position: Q1 2024 in Review
Cutler Group reduced its AbbVie (ABBV) stake by 11% in Q1 2024, selling an estimated $32.2K and leaving 1,480 shares worth $269K. The position accounts for 0.09% of the portfolio, ranked #226.
Cutler Group first reported a position in ABBV in Q4 2015 and has held it in 33 quarters since. The position peaked at $3.96M in Q4 2021. 3,379 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.
- Cutler Group held 1,480 shares of AbbVie worth $269K as of Q1 2024.
- Cutler Group sold 187 AbbVie shares in Q1 2024, an estimated $32.2K.
- AbbVie made up 0.09% of Cutler Group's portfolio in Q1 2024, its #226 holding.
- Cutler Group first reported a position in AbbVie in Q4 2015 and has held it in 33 quarters since.
- Cutler Group's AbbVie position peaked at $3.96M in Q4 2021.
- 3,379 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.
Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.